Related Experiment Video
Updated: May 9, 2026

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice
Published on: November 1, 2015
CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): a meta-analysis
Jin-Xia Zhai1, Li-Wei Zou, Zhao-Xiang Zhang
1Department of Occupational and Environmental Health, School of Public Health, Anhui Medical University, Hefei, Anhui, China.
This meta-analysis reveals that cytotoxic T-lymphocyte antigen-4 (CTLA-4) gene polymorphisms, specifically at exon-1 +49 and promoter -1722, are associated with systemic lupus erythematosus (SLE) susceptibility. These findings are particularly significant in Asian populations, suggesting a genetic link to SLE risk.
Area of Science:
- Immunogenetics
- Rheumatology
- Molecular Biology
Background:
- Systemic lupus erythematosus (SLE) is a complex autoimmune disease with a significant genetic component.
- Previous studies on the association between cytotoxic T-lymphocyte antigen-4 (CTLA-4) gene polymorphisms and SLE susceptibility have yielded inconsistent results.
- CTLA-4 plays a crucial role in regulating T-cell activation and immune tolerance.
Purpose of the Study:
- To conduct a meta-analysis to comprehensively summarize and assess the association between CTLA-4 promoter exon-1 +49 and 1722T/C polymorphisms and SLE susceptibility.
- To clarify the conflicting findings from previous individual studies.
- To evaluate the impact of these polymorphisms on SLE risk, particularly within different ethnic groups.
Main Methods:
- A systematic literature search was performed across major databases (PubMed, Elsevier Science Direct, CBM, CNKI, Wanfang) to identify relevant studies.
- A meta-analysis was conducted on 17 independent studies published up to June 2012.
- Allele and genotype frequencies of CTLA-4 exon-1 +49 and promoter -1722 polymorphisms were compared between SLE patients and controls.
Main Results:
- The meta-analysis demonstrated a significant association between the CTLA-4 exon-1 +49 polymorphism and SLE susceptibility in the Asian population.
- Specific genotypes (GG+GA) and alleles (G) of the exon-1 +49 polymorphism were linked to increased SLE risk in Asians.
- The CTLA-4 promoter -1722T/C polymorphism also showed a significant association with overall SLE risk in the Asian population.
Conclusions:
- The CTLA-4 gene polymorphisms at exon-1 +49 (A/G) and promoter -1722 (C/T) are associated with susceptibility to systemic lupus erythematosus.
- These genetic variations may contribute to the development of SLE, especially in individuals of Asian descent.
- The findings highlight the importance of CTLA-4 in SLE pathogenesis and suggest potential ethnic-specific genetic risk factors.
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
